Anodyne

Buprenorphine
Buprenorphine
Esters
[]
Buprenorphine palmitate
Buprenorphine palmitate
Molecular structure via molpic based on CDK
[]
Conformer structure via JSmol
Physical properties
[]
467.6 g/mol [1]
Solubility1.68e-02 g/L [1]
[1]
Structural Identifiers
[]
C29H41NO4 [1]
(1S,2S,6R,14R,15R,16R)-5-(cyclopropylmethyl)-16-[(2S)-2-hydroxy-3,3-dimethylbutan-2-yl]-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol [1]
C[C@]([C@H]1C[C@@]23CC[C@@]1([C@H]4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)(C(C)(C)C)O [1]
InChI=1S/C29H41NO4/c1-25(2,3)26(4,32)20-15-27-10-11-29(20,33-5)24-28(27)12-13-30(16-17-6-7-17)21(27)14-18-8-9-19(31)23(34-24)22(18)28/h8-9,17,20-21,24,31-32H,6-7,10-16H2,1-5H3/t20-,21-,24-,26+,27-,28+,29-/m1/s1 [1]
InChIKeyRMRJXGBAOAMLHD-IHFGGWKQSA-N [1]
Dosing
[]
Elimination half-life37 hours (range 20 – 70 hours)
Duration of action24 hours

Buprenorphine

Buprenorphine (also known as Temgesic, Buprenophine, Buprenorfina, Buprenorphinum, Butrans, buprenorphin, Probuphenine, Brixadi, Buvidal or CAM2038) is a opioid substance of the morphinan class.

Chemistry

Salts and Esters []

Buprenorphine is typically found in the form of its hydrochloride salt

or its ester.

 []

Buprenorphine is a absolute mixture

Subjective effects []

Experience reports []

Legal status []

  • Australia: Buprenorphine is a S8 substance.
  • Brazil: Buprenorphine is a A1 substance.[3]
  • Canada: Buprenorphine is a Schedule I substance.
  • Germany: Buprenorphine is a Anlage III substance.
  • United Kingdom: Buprenorphine is a Class C substance.
  • United States: Buprenorphine is a Schedule I under the "Controlled Substances Act (CSA)".
  • European Union: Buprenorphine is a prescription only substance.
  • United Nations: Buprenorphine is a Schedule III drug under the "Convention on Psychotropic Substances 1971".

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 644073, Buprenorphine. Accessed June 26, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/644073

  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Buprenorphine. UNII: 40D3SCR4GZ. Global Substance Registration System. Accessed June 26, 2025. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/40D3SCR4GZ

  3. Anvisa. RDC Nº 784 – Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. March 31, 2023. Accessed June 26, 2025. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992